190 related articles for article (PubMed ID: 23840303)
1. High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.
Zhang SH; Wang CJ; Shi L; Li XH; Zhou J; Song LB; Liao WT
PLoS One; 2013; 8(6):e64709. PubMed ID: 23840303
[TBL] [Abstract][Full Text] [Related]
2. Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.
Chen J; Liu WB; Jia WD; Xu GL; Ma JL; Ren Y; Chen H; Sun SN; Huang M; Li JS
PLoS One; 2014; 9(1):e85840. PubMed ID: 24465741
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of FLOT1 correlates with tumor progression and poor survival in patients with non-small cell lung cancer.
Li H; Wang RM; Liu SG; Zhang JP; Luo JY; Zhang BJ; Zhang XG
Tumour Biol; 2014 Apr; 35(4):3311-5. PubMed ID: 24277378
[TBL] [Abstract][Full Text] [Related]
4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
6. CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.
Chen B; Shen S; Wu J; Hua Y; Kuang M; Li S; Peng B
Int J Clin Exp Pathol; 2015; 8(10):13725-38. PubMed ID: 26722601
[TBL] [Abstract][Full Text] [Related]
7. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
[TBL] [Abstract][Full Text] [Related]
8. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma.
Hu GS; Li YQ; Yang YM; Shi W; Liao AJ; Yao YH; Zeng B; Yuan J
Tumour Biol; 2014 Sep; 35(9):8625-32. PubMed ID: 24867097
[TBL] [Abstract][Full Text] [Related]
9. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancer.
Li H; Zhang Y; Chen SW; Li FJ; Zhuang SM; Wang LP; Zhang J; Song M
Int J Clin Exp Pathol; 2014; 7(3):996-1003. PubMed ID: 24695539
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
12. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
13. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
[TBL] [Abstract][Full Text] [Related]
14. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
16. Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells.
Song L; Gong H; Lin C; Wang C; Liu L; Wu J; Li M; Li J
Gastroenterology; 2012 Oct; 143(4):995-1005.e12. PubMed ID: 22732732
[TBL] [Abstract][Full Text] [Related]
17. Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients.
Han CP; Yu YH; Wang AG; Tian Y; Zhang HT; Zheng ZM; Liu YS
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5481-5489. PubMed ID: 30229819
[TBL] [Abstract][Full Text] [Related]
18. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
20. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
